Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
for
Advanced Melanoma
Location: Houston TX, Los Angeles CA, Basking Ridge NJ,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06594991
Phase 2, Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
for
Breast Cancer, Advanced Solid Tumor
Location: Houston TX, Austin TX, Birmingham AL, St Louis MO,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07222267
Phase 1, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for
Overweight, Obesity
Location: Houston TX, Austin TX, Corpus Christi TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07282600
Phase 3, Recruiting
The Gut Microbiome and Immunotherapy Response in Solid Cancers
for
Cancer
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston
Sex: All
Age: 35 - 70+
Code: NCT06050733
Recruiting
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
Location: Houston TX, Tampa FL, Ann Arbor MI, Washington, D.C. DC,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 12+
Code: NCT05668962
Phase 2, Recruiting
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
for
Advanced Solid Tumors, Ewing Sarcoma,
Location: Houston TX, Newport Beach CA, Duarte CA, New York NY,
Sponsor: SEED Therapeutics, Inc.
Sex: All
Age: 16+
Code: NCT07197554
Phase 1, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
for
Liposarcoma, Prostate Cancer, Advanced Breast Cancer,
Location: Houston TX, Nashville TN, Grand Rapids MI,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT04557449
Phase 2, Recruiting
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
for
Pancreatic Carcinoma
Location: Houston TX, Atlanta GA, Omaha NE, Peoria IL,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06271291
Recruiting
Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100
for
Ovarian Clear Cell Carcinoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06065462
Phase 1, Phase 2, Recruiting
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
for
Myasthenia Gravis
Location: Houston TX, Austin TX, Dallas TX, New Orleans LA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18 - 70+
Code: NCT07217587
Phase 3, Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
for
Type 1 Diabetes
Location: Houston TX, San Antonio TX, Dallas TX, Fort Worth TX,
Sponsor: SAb Biotherapeutics, Inc.
Sex: All
Age: 5 - 40
Code: NCT07187531
Phase 2, Recruiting
A Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma
for
Metastatic Endocrine Refractory,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07229417
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of MK-1406/CD388 for Prevention of Influenza (MK-1406-005/CD388.SQ.3.06)
for
Influenza
Location: Houston TX, Dallas TX, Plano TX, Prairieville LA,
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Sex: All
Age: 12+
Code: NCT07159763
Phase 3, Recruiting
Self-sampling to Optimize Anal Lesion Outcomes
for
Anal Cancer
Location: Houston TX, Chicago IL, Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 35+
Code: NCT07192055
Recruiting
Want a closer look at research in Houston? Read our guide: Clinical Trials in Houston: Why the City Leads the Country